We are tackling the exam glove shortage

February 26, 2021 Providence News Team

As we’ve seen throughout this pandemic, some medical supplies needed for COVID-19 care have struggled to keep pace with growing global demand. Currently, we’re seeing exam gloves in short supply because there are not enough raw materials for manufacturers to make them.

Our supply chain leaders in Resource, Engineering and Hospitality (REH) are tracking this issue carefully. They are working to get exam gloves to meet current and future demands, and the needs of our caregivers and patients.

To meet our demand, we will source gloves from more than one supplier. While all gloves we put into circulation meet safety standards, they may vary in look and feel depending on the supplier.

We closely monitor inventory for all PPE and will continue to work with trusted manufacturers to ensure sufficient supply for our providers, caregivers and patients. To track our status each week, see the supplies dashboard under “COVID-19 Quick Links” on the COVID-19 SharePoint Online site.

About the Author

The Providence News Team brings you the updates to keep you informed about what's happening across the organizational ecosystem. From partnerships to new doctor announcements, we are committed to keeping you informed.
More Content by Providence News Team

Welcome to your journey for creating a healthier you

We are tackling the exam glove shortage

About the Author

Previous Article

Next Article

We are tackling the exam glove shortage

About the Author

Previous Article

Next Article

Most Recent Articles

Learn about vaccine safety and effectiveness, benefits and next steps for caregivers.

Health officials determine that the vaccine is safe and effective for preventing COVID-19.

The CDC and FDA recommended a pause on the administration of Janssen’s Johnson & Johnson one-dose COVID-19 vaccine while health authorities review rare blood clotting cases.

CDC released studies emphasizing importance of filtration and well-fitting masks to prevent spread of infection and exposure to COVID-19.

The Johnson & Johnson vaccine marks the third candidate for Emergency Use Authorization.

With an increasing number of caregivers and patients now vaccinated, it’s important to remember that everyone still needs to continue to follow COVID-19 safety practices.

As you prepare to receive your second dose of COVID-19 vaccine, the following tips and reminders will improve your experience.

A new coronavirus strain, first detected in the United Kingdom, has made its way to the U.S. with confirmed cases reported in several states.

Thousands of patients with COVID-19 are in our care.

Please review the eligibility requirements prior to receiving the COVID-19 vaccine.

Watch Rod’s vaccine Town Hall and read his message about caregiver benefits.

We can begin offering vaccine to our highest-risk, front-line caregivers soon.

The decision was made after an FDA advisory committee reviewed and validated data showing the vaccine to be safe and highly effective.

Because we are expecting a limited supply initially, the first vaccinations will be based on risk, role and work location.

To help us plan distribution of the first doses of the COVID-19 vaccine, we are asking you to complete our online Validate and Verify (VAV) tool.

At least two COVID-19 vaccines are expected to receive FDA emergency use authorization in a matter of days.

Providence offers a glimpse into the current state of developing a COVID-19 vaccine.

Providence is preparing caregivers for the rollout of the COVID-19 vaccine. Learn more about the organization's rollout plan.